background
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
inde
sar
epidem
taiwan
march
juli
great
impact
studi
depict
clinic
characterist
shortterm
outcom
patient
sar
treat
taipei
veteran
gener
hospit
potenti
predict
factor
acut
respiratori
distress
syndrom
ard
also
analyz
method
studi
retrospect
analyz
data
sar
patient
group
accord
whether
ard
develop
clinic
cours
sar
result
male
mean
age
year
rang
year
femal
mean
age
year
rang
year
twentyf
patient
health
care
worker
admiss
patient
abnorm
chest
radiograph
patient
develop
pulmonari
infiltr
follow
week
hospit
lymphopenia
found
patient
elev
level
lactat
dehydrogenas
ldh
n
creactiv
protein
n
aminotransferas
n
creatin
kinas
n
also
note
ard
develop
patient
gener
older
patient
ard
develop
male
nonhealth
care
worker
gener
dyspnea
time
diagnosi
histori
diabet
mellitu
hypertens
cerebrovascular
accid
patient
versu
without
ard
also
tend
present
sever
lymphopenia
leukocytosi
higher
level
ldh
aspart
aminotransferas
overal
mortal
rate
wherea
rate
patient
develop
ard
multivari
analys
show
age
greater
year
odd
ratio
confid
interv
ci
preexist
diabet
mellitu
ci
elev
level
ldh
ci
admiss
independ
predictor
ard
clinic
manifest
sar
show
high
variabl
relat
underli
health
statu
individu
patient
importantli
develop
ard
associ
signific
mortal
despit
aggress
therapi
j
chin
med
assoc
sever
acut
respiratori
syndrom
sar
infecti
pulmonari
diseas
appear
origin
southern
china
fall
diseas
spread
part
asia
europ
north
america
case
report
worldwid
first
two
sar
case
taiwan
diagnos
coupl
march
man
travel
guangdong
provinc
hong
kong
februari
coupl
treat
success
intens
care
unit
icu
medic
center
subsequ
sar
patient
treat
medic
center
two
cluster
case
note
late
april
taipei
origin
outbreak
laundri
worker
age
year
diabet
mellitu
employ
hospit
b
index
patient
symptomat
day
sar
diagnos
number
potenti
expos
person
estim
patient
visitor
staff
within
less
week
anoth
outbreak
sar
cluster
occur
hospit
c
near
hospit
b
taipei
veteran
gener
hospit
undertook
care
critic
ill
sar
patient
mainli
transfer
hospit
b
hospit
c
caus
sar
novel
coronaviru
natur
clinic
histori
rang
febril
respiratori
symptom
without
hypoxemia
respiratori
distress
requir
intub
occasion
result
death
worldwid
substanti
mortal
associ
sar
vari
markedli
paper
provid
retrospect
review
predict
factor
acut
respiratori
distress
syndrom
ard
patient
sar
treat
taipei
veteran
gener
hospit
follow
criteria
use
evalu
probabl
sar
histori
close
contact
sar
patient
evid
travel
sarsendem
area
within
day
symptom
onset
acut
onset
fever
c
respiratori
symptom
includ
cough
dyspnea
chest
radiograph
show
patchi
spotti
pulmonari
infiltr
ard
without
identifi
caus
evid
transmiss
pneumonia
patient
fulfil
criteria
defin
suspect
case
meet
criteria
defin
probabl
case
diagnosi
sar
made
altern
diagnosi
could
fulli
explain
ill
revers
transcriptasepolymeras
chain
reaction
rtpcr
antibodi
sarscoronaviru
sarscov
use
confirm
diagnosi
part
diagnost
criteria
studi
includ
patient
sar
admit
taipei
veteran
gener
hospit
march
juli
even
though
case
cohort
report
previous
chiang
et
al
thirtythre
patient
refer
due
evid
sar
note
anoth
hospit
patient
categor
accord
sever
clinic
condit
ie
nonard
ard
ard
defin
accord
americaneuropean
consensu
confer
nonard
patient
ratio
partial
arteri
oxygen
pressur
pao
fraction
inspir
oxygen
fio
mmhg
develop
ard
stay
ward
ard
patient
pao
fio
mmhg
bilater
lung
infiltr
admiss
stay
ward
patient
isol
treatment
includ
antibiot
prevent
secondari
bacteri
infect
choic
antibiot
base
empir
knowledg
common
atyp
pathogen
encount
commun
antibiot
administ
patient
establish
bacteri
infect
accord
result
drugsensit
test
bacteri
cultur
administr
ribavirin
intraven
immunoglobulin
corticosteroid
determin
physician
patient
intub
respiratori
failur
develop
ie
pao
administr
supplement
oxygen
without
respiratori
rate
breath
per
minut
clinic
databas
construct
document
patient
demograph
includ
follow
date
onset
initi
symptom
initi
abnorm
radiograph
find
date
admiss
hospit
tracheal
intub
mechan
ventil
comorbid
condit
treatment
shortterm
outcom
acut
ill
main
paramet
monitor
everi
day
hospit
admiss
compris
complet
blood
count
cbc
aspart
aminotransferas
ast
alanin
aminotransferas
alt
blood
urea
nitrogen
creatinin
creatin
kinas
ck
lactat
dehydrogenas
ldh
creactiv
protein
crp
blood
gase
chest
film
taken
daili
earli
hospit
stay
everi
day
convalesc
rtpcr
sarscov
perform
routin
nasopharyng
swab
day
hospit
assay
antisarscov
antibodi
perform
day
hospit
week
hospit
discharg
compar
differ
epidemiolog
clinic
laboratori
measur
patient
develop
ard
squareroot
transform
perform
cbc
biochem
paramet
normal
data
kolmogorovsmirnov
test
use
check
normal
student
test
adapt
normaldistribut
data
continu
variabl
fit
normal
distribut
median
interquartil
rang
iqr
calcul
summari
distribut
wilcoxon
ranksum
test
adapt
comparison
chisquar
test
use
compar
categori
variabl
calcul
odd
ratio
ard
logist
regress
analysi
variabl
dichotom
use
normallimit
valu
cutoff
except
crp
cutoff
mgl
age
year
dichotom
variabl
comorbid
studi
group
divid
patient
valu
without
underli
diseas
valu
p
valu
less
consid
statist
signific
analys
carri
use
statist
packag
social
scienc
version
spss
inc
chicago
il
usa
total
patient
sar
admit
hospit
march
juli
repres
document
probabl
sar
case
taiwan
patient
compris
men
women
mean
age
standard
deviat
sd
year
rang
year
tabl
twentyf
patient
medic
profession
other
variou
occup
thirtythre
patient
requir
mechan
ventilatori
support
patient
without
ard
significantli
younger
patient
ard
year
vs
year
patient
receiv
nasopharyngealswab
rtpcr
test
routin
day
hospit
patient
posit
find
thirtythre
patient
assay
antisarscov
antibodi
day
hospit
posit
find
common
initi
clinic
symptom
fever
patient
cough
dyspnea
wateri
diarrhea
note
less
patient
fortytwo
patient
comorbid
condit
princip
includ
diabet
mellitu
n
viral
hepat
n
hypertens
n
cerebrovascular
accid
cva
n
levofloxacin
use
total
patient
wherea
antibiot
use
significantli
frequent
patient
ard
rather
without
vs
p
administr
ribavirin
intraven
immunoglobulin
corticosteroid
differ
significantli
patient
ard
without
although
puls
corticosteroid
therapi
methylprednisolon
mg
intraven
everi
hour
day
given
four
patient
ard
versu
none
nonard
patient
p
mean
length
hospit
stay
significantli
shorter
patient
without
ard
survivor
ard
day
vs
day
p
tabl
overal
mortal
rate
patient
wherea
mortal
rate
patient
underw
mechan
ventil
laboratori
indic
hospit
summar
tabl
sixteen
patient
leukocyt
count
lymphocyt
count
chest
radiograph
reveal
chang
relat
pneumonia
although
patient
pulmonari
infiltr
initi
radiograph
combin
central
peripher
lesion
evid
patient
rapid
progress
singl
local
lesion
common
locat
bilater
lower
lung
region
tabl
patient
initi
normal
radiograph
subsequ
develop
consolid
averag
time
fever
onset
abnorm
radiograph
day
rang
day
use
logist
multipl
regress
model
uncov
risk
factor
develop
ard
model
includ
ldh
crp
age
year
diabet
mellitu
hypertens
previou
cva
male
gender
univari
logist
regress
analys
odd
ratio
ard
develop
patient
sar
tabl
taiwan
third
largest
number
sar
case
hong
kong
china
date
howev
larg
formal
analysi
data
taiwan
sinc
hospit
respons
manag
critic
case
northern
taiwan
outcom
shown
sever
medic
set
initi
clinic
present
laboratori
featur
similar
seri
symptom
acut
respiratori
distress
develop
half
patient
patient
die
discharg
hospit
risk
factor
ard
age
year
diabet
mellitu
elev
ldh
level
research
also
document
independ
predictor
associ
poor
outcom
eg
acut
ill
lead
death
need
mechan
ventil
icu
admiss
diagnosi
sar
base
comprehens
contact
histori
precis
laboratori
test
world
health
organ
diagnost
criteria
sar
report
sensit
specif
wherea
sensit
laboratori
test
sarscov
less
sinc
contact
histori
reliabl
sar
cluster
case
note
commun
group
one
need
highli
suspici
transmiss
pneumonia
inclus
criteria
ad
compon
transmiss
pneumonia
high
degre
clinic
diagnost
accuraci
confirm
laboratori
test
hematolog
abnorm
especi
lymphopenia
common
cohort
probabl
ribavirin
therapi
intraven
immunoglobulin
given
sever
hematolog
abnorm
occur
pancytopenia
hemophagocytosi
note
patient
without
ard
phenomenon
note
viral
infect
outcom
fair
support
treatment
cohort
elev
ast
obviou
alt
ard
group
sinc
carrier
hepat
b
viru
show
profound
lung
injuri
whether
sarscov
interact
hepat
b
viru
yet
clear
locat
pulmonari
infiltr
sar
patient
report
peripher
lung
cohort
initi
infiltr
lesion
mainli
locat
central
peripher
lung
best
explan
anterior
posterior
peripher
lesion
would
project
central
locat
posteroanterior
chest
radiograph
efficaci
treatment
difficult
evalu
patient
usual
receiv
combin
medic
includ
antivir
broadspectrum
antibacteri
corticosteroid
drug
addit
support
therapi
initi
caus
sar
thought
atyp
pathogen
patient
receiv
empir
antibacteri
therapi
fluoroquinolon
levofloxacin
drug
choic
patient
broadspectrum
activ
anaerob
aerob
gramposit
gramneg
bacteria
patient
develop
ard
stronger
antibiot
fourthgener
cephalosporin
teicoplanin
carbapenem
often
use
proven
effect
treatment
sar
henc
differ
proport
patient
per
group
receiv
antivir
ribavirin
intraven
immunoglobulin
moder
amount
corticosteroid
howev
puls
corticosteroid
therapi
often
use
ard
nonard
patient
studi
sever
limit
retrospect
standard
medic
chart
follow
clinic
cours
import
inform
may
therefor
lost
may
led
bia
comparison
date
howev
largest
clinic
analysi
sar
taiwan
